Patents by Inventor Edward T. Maggio

Edward T. Maggio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Administration of benzodiazepine compositions
    Patent number: 12337061
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: April 15, 2022
    Date of Patent: June 24, 2025
    Assignee: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • Administration of benzodiazepine compositions
    Patent number: 12268664
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: July 24, 2024
    Date of Patent: April 8, 2025
    Assignee: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • COMPOSITIONS, DEVICES, AND METHODS FOR THE TREATMENT OF OVERDOSE AND REWARD-BASED DISORDERS
    Publication number: 20240408004
    Abstract: Drug products adapted for nasal delivery, comprising a device filled with a pharmaceutical composition comprising naltrexone are provided. Formulations and methods of treating alcohol use disorder and related conditions with the drug products are also provided.
    Type: Application
    Filed: December 21, 2023
    Publication date: December 12, 2024
    Applicants: Aegis Therapeutics, LLC, Indivior UK Limited
    Inventors: Edward T. MAGGIO, Roger CRYSTAL, Mark ELLISON, Phil SKOLNICK, Arvind AGRAWAL
  • COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL USE DISORDER
    Publication number: 20240408003
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising naltrexone are provided. Formulations and methods of treating alcohol use disorder and related conditions with the drug products are also provided.
    Type: Application
    Filed: December 21, 2023
    Publication date: December 12, 2024
    Applicants: Indivior UK Limited, Aegis Therapeutics, LLC
    Inventors: Roger CRYSTAL, Arvind AGRAWAL, Edward T. MAGGIO
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20240374556
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: July 24, 2024
    Publication date: November 14, 2024
    Applicant: Neurelis, Inc.
    Inventors: Steve CARTT, David MEDEIROS, Garry Thomas GWOZDZ, Andrew LOXLEY, Mark MITCHNICK, David F. HALE, Edward T. MAGGIO
  • FORMULATIONS AND METHODS FOR THE PREVENTION OF OPIOID OVERDOSE
    Publication number: 20240197719
    Abstract: Formulations and methods for the preventative treatment of incidental opioid overdose comprising the intranasal (IN) administration of a pharmaceutical formulation containing the opioid antagonist nalmefene as a prophylactic measure.
    Type: Application
    Filed: February 8, 2024
    Publication date: June 20, 2024
    Applicants: Aegis Therapeutics, LLC, Indivior Inc.
    Inventors: Roger CRYSTAL, Phil SKOLNICK, Edward T. MAGGIO
  • Intranasal epinephrine formulations and methods for the treatment of disease
    Patent number: 11918655
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Grant
    Filed: June 7, 2023
    Date of Patent: March 5, 2024
    Assignee: AEGIS THERAPEUTICS, LLC
    Inventors: Richard Lowenthal, Edward T. Maggio, Robert G. Bell, Pratik Shah
  • INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
    Publication number: 20240024485
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Application
    Filed: June 7, 2023
    Publication date: January 25, 2024
    Inventors: Richard LOWENTHAL, Edward T. MAGGIO, Robert G. BELL, Pratik SHAH
  • Administration of benzodiazepine compositions
    Patent number: 11793786
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: April 12, 2021
    Date of Patent: October 24, 2023
    Assignee: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
    Publication number: 20230302137
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Application
    Filed: June 1, 2023
    Publication date: September 28, 2023
    Inventors: Richard LOWENTHAL, Edward T. MAGGIO, Robert G. BELL, Pratik SHAH
  • Intranasal epinephrine formulations and methods for the treatment of disease
    Patent number: 11744895
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: September 5, 2023
    Assignee: AEGIS THERAPEUTICS, LLC
    Inventors: Richard Lowenthal, Edward T. Maggio, Robert G. Bell, Pratik Shah
  • Intranasal epinephrine formulations and methods for the treatment of disease
    Patent number: 11717571
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Grant
    Filed: October 26, 2022
    Date of Patent: August 8, 2023
    Assignee: AEGIS THERAPEUTICS, LLC
    Inventors: Richard Lowenthal, Edward T. Maggio, Robert G. Bell, Pratik Shah
  • Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid Overdose
    Publication number: 20230225961
    Abstract: Methods, pharmaceutical formulations and devices for the preventative treatment of incidental opioid overdose comprising the intramuscular or subcutaneous administration using an auto-injection device of a pharmaceutical formulation containing the opioid antagonist nalmefene as a prophylactic measure.
    Type: Application
    Filed: February 27, 2023
    Publication date: July 20, 2023
    Inventors: Roger Crystal, Phil Skolnick, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20230104144
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: December 6, 2022
    Publication date: April 6, 2023
    Applicant: Neurelis, Inc.
    Inventors: Steve CARTT, David MEDEIROS, Garry Thomas GWOZDZ, Andrew LOXLEY, Mark MITCHNICK, David F. HALE, Edward T. MAGGIO
  • INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
    Publication number: 20230085636
    Abstract: Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided.
    Type: Application
    Filed: October 26, 2022
    Publication date: March 23, 2023
    Inventors: Richard LOWENTHAL, Edward T. MAGGIO, Robert G. BELL, Pratik SHAH
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPIOID OVERDOSE
    Publication number: 20220387306
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising nalmefene are provided. Methods of treating opioid overdose with the drug products are also provided.
    Type: Application
    Filed: August 4, 2022
    Publication date: December 8, 2022
    Applicants: Opiant Pharmaceuticals, Inc., Aegis Therapeutics, LLC
    Inventors: Roger CRYSTAL, Edward T. MAGGIO
  • Compositions and methods for the treatment of opioid overdose
    Patent number: 11458091
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising nalmefene are provided. Methods of treating opioid overdose with the drug products are also provided.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: October 4, 2022
    Assignees: Opiant Pharmaceuticals, Inc., Aegis Therapeutics, LLC
    Inventors: Roger Crystal, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20220241187
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: April 15, 2022
    Publication date: August 4, 2022
    Applicant: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • METHODS AND COMPOSITIONS FOR RAPID DELIVERY OF ANTI-SEIZURE THERAPEUTICS
    Publication number: 20220218598
    Abstract: Compositions for intranasal delivery of benzodiazepines and methods for their use to treat and prevent seizures are provided. The compositions deliver rapid therapeutic onset with a decreased incidence and/or severity of adverse effects after administration. Additionally, use of the compositions for the treatment of seizure clusters increases the time to a second seizure and duration of the interseizure cluster interval.
    Type: Application
    Filed: January 7, 2022
    Publication date: July 14, 2022
    Applicant: Neurelis, Inc.
    Inventors: Sunita Misra, Enrique J. Carrazana, Adrian L. Rabinowicz, Stuart Madden, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20220117887
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: June 2, 2021
    Publication date: April 21, 2022
    Applicant: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio